53: Current Topics in Women's Health: Vaginal Secretions as a Perfume?

Welcome to Dr. Tassone's tips and tricks for the news cycle of the day! Today, I'm doing things differently and talking about the women's health topics that are doing the rounds on the news and social media. I'll be sharing what you need to know about these topics, separating the truth from the fiction, and empowering you to be the best advocate for your health. In this episode, I'm exploring the new over-the-counter birth control pill, TikTok trends, the rising cost of healthcare, issues with telehealth, and more. Enjoy the episode!   Highlights What you need to know about Opill, the new over-the-counter birth control pill Pros and cons of using Opill My thoughts on Texas' low ranking in women's health Tips for safeguarding vaginal health during the summer Debunking the TikTok trend of vaginal secretions as perfume Potential benefits and drawbacks of telehealth Censorship of women's health issues on social media platforms The financial burden faced by women experiencing menopause   This episode is sponsored by Femmenessence It's a rare occurrence to find a non-prescription supplement that becomes a go-to for hormone health and Femmenessence is just that. Whether you're pre-menopausal, menopausal, or struggling with PMS, irregular periods, or other hormone imbalances, I highly recommend giving Femmenessence a try. Visit Femmenessence.com (https://femmenessence.com/) and use code SHAWN20 for exclusive savings.   Resources Dr. Tassone's Practice https://www.drshawntassone.com/ The Hormone Balance Bible https://tassonemd.com/hormone-balance-bible/ Hormone Archetype Quiz https://tassonemd.lpages.co/hormonearchetypequiz/   Disclaimer This podcast and website represent the opinions of Dr. Shawn Tassone and his guests. The content here should not be taken as medical advice and is for informational purposes only. Because each person is so unique, please consult your health care professional for any medical questions.

There are no comments yet.

Please log in to write the first comment.